• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Pharmacokinetic analysis of transcellular transport of quinidine across monolayers of human intestinal epithelial Caco-2 cells.

作者信息

Ishida Kazuya, Takaai Mari, Hashimoto Yukiya

机构信息

Graduate School of Pharmaceutical Sciences, University of Toyama, Sugitani, Japan.

出版信息

Biol Pharm Bull. 2006 Mar;29(3):522-6. doi: 10.1248/bpb.29.522.

DOI:10.1248/bpb.29.522
PMID:16508158
Abstract

To investigate the mechanism responsible for the intestinal absorption of a lipophilic organic cation, quinidine, we performed a pharmacokinetic analysis of transcellular transport across Caco-2 cell monolayers grown on a porous membrane. Basolateral-to-apical transport of the drug was almost constant in the concentration range of 100 nM-100 microM. Transcellular transport was greater in the apical-to-basolateral direction than in the opposite direction. Apical-to-basolateral transport was greater at a concentration of 100 microM than 100 nM. The calculated influx clearance value of the apical membrane was much greater than the other influx/efflux clearance values of cell membranes, and was 5.6-fold the influx clearance value of the basolateral membrane at the drug concentration of 100 microM. We also investigated the uptake of quinidine at the apical membrane of Caco-2 cells grown on plastic dishes. The uptake was markedly increased by alkalization of the apical medium at 37 degrees C, and was decreased at low temperature (4 degrees C). In addition, it was inhibited by diphenhydramine and levofloxacin, but not by carvedilol, rifamycin SV, or L-carnitine. These findings indicated that the influx at the apical membrane was the direction-determining step in the transcellular transport of quinidine across Caco-2 cell monolayers, and that some specific transport system was involved in this influx.

摘要

相似文献

1
Pharmacokinetic analysis of transcellular transport of quinidine across monolayers of human intestinal epithelial Caco-2 cells.
Biol Pharm Bull. 2006 Mar;29(3):522-6. doi: 10.1248/bpb.29.522.
2
Pharmacokinetic analysis of transcellular transport of levofloxacin across LLC-PK1 and Caco-2 cell monolayers.左氧氟沙星经细胞转运穿过LLC-PK1和Caco-2细胞单层的药代动力学分析。
Biol Pharm Bull. 2007 Nov;30(11):2167-72. doi: 10.1248/bpb.30.2167.
3
Membrane transport mechanisms of quinidine and procainamide in renal LLC-PK1 and intestinal LS180 cells.奎尼丁和普鲁卡因胺在肾 LLC-PK1 和肠 LS180 细胞中的膜转运机制。
Biol Pharm Bull. 2010;33(8):1407-12. doi: 10.1248/bpb.33.1407.
4
Directional transcellular transport of bisoprolol in P-glycoprotein-expressed LLC-GA5-COL150 cells, but not in renal epithelial LLC-PK1 Cells.比索洛尔在表达P-糖蛋白的LLC-GA5-COL150细胞中存在定向跨细胞转运,但在肾上皮LLC-PK1细胞中不存在。
Drug Metab Pharmacokinet. 2008;23(5):340-6. doi: 10.2133/dmpk.23.340.
5
The apical uptake transporter of levofloxacin is distinct from the peptide transporter in human intestinal epithelial Caco-2 cells.左氧氟沙星的顶端摄取转运体与人肠上皮Caco-2细胞中的肽转运体不同。
Drug Metab Pharmacokinet. 2008;23(5):373-8. doi: 10.2133/dmpk.23.373.
6
Mechanisms for membrane transport of metformin in human intestinal epithelial Caco-2 cells.人肠道上皮细胞 Caco-2 中二甲双胍的膜转运机制。
Biopharm Drug Dispos. 2011 Jul;32(5):253-60. doi: 10.1002/bdd.755. Epub 2011 May 13.
7
Pharmacokinetic characterization of transcellular transport and drug interaction of digoxin in Caco-2 cell monolayers.地高辛在Caco-2细胞单层中的跨细胞转运及药物相互作用的药代动力学特征
Biol Pharm Bull. 2005 Jan;28(1):114-9. doi: 10.1248/bpb.28.114.
8
Transepithelial transport of diphenhydramine across monolayers of the human intestinal epithelial cell line Caco-2.苯海拉明经人肠上皮细胞系Caco-2单层的跨上皮转运
Pharm Res. 2000 May;17(5):539-45. doi: 10.1023/a:1007560731098.
9
Secretory mechanisms of grepafloxacin and levofloxacin in the human intestinal cell line caco-2.格帕沙星和左氧氟沙星在人肠上皮细胞系Caco-2中的分泌机制。
J Pharmacol Exp Ther. 2000 Oct;295(1):360-6.
10
Transcellular transport of domoic acid across intestinal Caco-2 cell monolayers.跨肠道 Caco-2 细胞单层的脱氢枞酸的细胞间转运。
Food Chem Toxicol. 2011 Sep;49(9):2167-71. doi: 10.1016/j.fct.2011.06.001. Epub 2011 Jun 6.

引用本文的文献

1
Reliability of in vitro data for the mechanistic prediction of brain extracellular fluid pharmacokinetics of P-glycoprotein substrates in vivo; are we scaling correctly?用于体内P-糖蛋白底物脑细胞外液药代动力学机制预测的体外数据的可靠性;我们的缩放是否正确?
J Pharmacokinet Pharmacodyn. 2025 Feb 8;52(2):16. doi: 10.1007/s10928-025-09963-w.
2
Transport of perfluoroalkyl substances across human induced pluripotent stem cell-derived intestinal epithelial cells in comparison with primary human intestinal epithelial cells and Caco-2 cells.人诱导多能干细胞衍生肠上皮细胞与原代人肠上皮细胞和 Caco-2 细胞比较的全氟烷基物质转运。
Arch Toxicol. 2024 Nov;98(11):3777-3795. doi: 10.1007/s00204-024-03851-x. Epub 2024 Aug 31.
3
Validation of quinidine as a probe substrate for the in vitro P-gp inhibition assay in Caco-2 cell monolayer.
奎尼丁作为Caco-2细胞单层体外P-糖蛋白抑制试验的探针底物的验证。
Eur J Drug Metab Pharmacokinet. 2011 Sep;36(3):115-9. doi: 10.1007/s13318-011-0046-9. Epub 2011 Jul 2.
4
Evaluation of in vivo P-glycoprotein phenotyping probes: a need for validation.体内 P-糖蛋白表型探针的评价:验证的必要性。
Clin Pharmacokinet. 2010 Apr;49(4):223-37. doi: 10.2165/11318000-000000000-00000.
5
Mechanistic analysis of chemical permeation enhancers for oral drug delivery.用于口服给药的化学渗透促进剂的作用机制分析
Pharm Res. 2008 Jun;25(6):1412-9. doi: 10.1007/s11095-008-9542-2.